TestCard

TestCard is a UK-based digital health company whose platform technology turns any camera-enabled smartphone or tablet into a clinical-grade diagnostic scanner. The company's ClearScreen product enables accurate, automated reading, recording, and reporting of lateral flow and urine dipstick test results — without the subjective error of visual interpretation. TestCard partners with NHS trusts, pharmaceutical companies (Roche), cancer research organizations (Yorkshire Cancer Research, Cancer Research UK), and pharmacy chains (Superdrug) to deploy its technology across clinical settings, research programs, and at-home testing. Founded in 2017, the company has raised approximately $19M and its platform integrates with electronic patient record systems and middleware solutions while storing no patient data on-device.